WIT Dyne Health's Unit Gets Registration Certificate for Simethicone Emulsion

MT Newswires Live11-22

Shandong WIT Dyne Health's (SHE:000915) unit, Shandong Dayin Marine Biopharmaceutical, received a drug registration certificate from the Chinese drug administration for the drug simethicone emulsion, according to a Shenzhen Stock Exchange filing on Friday.

The drug is used to treat discomfort caused by excessive gas accumulation in the gastrointestinal tract. It can also be an auxiliary drug for abdominal imaging examinations and as an additive for contrast agent suspension for double contrast display.

The certificate is valid until Nov. 14, 2029, the Chinese pharmaceutical company said.

The company's shares closed more than 4% lower.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2485804432?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-22 16:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2485804432","market":"fut","top_or_hot":-1,"title":"WIT Dyne Health's Unit Gets Registration Certificate for Simethicone Emulsion","media":"MT Newswires Live","content":"<html><body><p> Shandong WIT Dyne Health's (SHE:000915) unit, Shandong Dayin Marine Biopharmaceutical, received a drug registration certificate from the Chinese drug administration for the drug simethicone emulsion, according to a Shenzhen Stock Exchange filing on Friday.</p><p>The drug is used to treat discomfort caused by excessive gas accumulation in the gastrointestinal tract. It can also be an auxiliary drug for abdominal imaging examinations and as an additive for contrast agent suspension for double contrast display.</p><p>The certificate is valid until Nov. 14, 2029, the Chinese pharmaceutical company said.</p><p>The company's shares closed more than 4% lower.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WIT Dyne Health's Unit Gets Registration Certificate for Simethicone Emulsion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWIT Dyne Health's Unit Gets Registration Certificate for Simethicone Emulsion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-22 16:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shandong WIT Dyne Health's (SHE:000915) unit, Shandong Dayin Marine Biopharmaceutical, received a drug registration certificate from the Chinese drug administration for the drug simethicone emulsion, ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0175","symbol_name":"白马股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2485804432","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2485804432","pubTimestamp":1732262455,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shandong WIT Dyne Health's  unit, Shandong Dayin Marine Biopharmaceutical, received a drug registration certificate from the Chinese drug administration for the drug simethicone emulsion, according to a Shenzhen Stock Exchange filing on Friday.The drug is used to treat discomfort caused by excessive gas accumulation in the gastrointestinal tract. It can also be an auxiliary drug for abdominal imaging examinations and as an additive for contrast agent suspension for double contrast display.The certificate is valid until Nov. 14, 2029, the Chinese pharmaceutical company said.The company's shares closed more than 4% lower.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0175":"白马股","BK4134":"信息科技咨询与其它服务","BK0186":"小盘成长","BK0239":"医药制造","WIT":"Wipro Limited","BK4523":"印度概念","BK0122":"高校","000915":"华特达因","BK0188":"融资融券"},"translate_title":"WIT Dyne Health子公司获得西甲硅油乳液注册证","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WIT":1,"000915":0.9},"content_text":"Shandong WIT Dyne Health's (SHE:000915) unit, Shandong Dayin Marine Biopharmaceutical, received a drug registration certificate from the Chinese drug administration for the drug simethicone emulsion, according to a Shenzhen Stock Exchange filing on Friday.The drug is used to treat discomfort caused by excessive gas accumulation in the gastrointestinal tract. It can also be an auxiliary drug for abdominal imaging examinations and as an additive for contrast agent suspension for double contrast display.The certificate is valid until Nov. 14, 2029, the Chinese pharmaceutical company said.The company's shares closed more than 4% lower.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2485804432"}